Albumin-bilirubin score: Monitoring hepatic function in patients with chronic hepatitis C virus infection
World Journal of Hepatology · 27.07.2026 · 18 (7)
DOI: 10.4254/wjh.114187 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Hepatology, online erschienen am 27.07.2026. Verfasst von Elsie A Jiménez-Cuevas und 4 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Chronic hepatitis C virus (HCV) infection is a global public health concern that affects millions of people, decreasing patient quality of life and increasing health care costs. The current gold standard for assessing liver fibrosis is liver biopsy, an invasive method that can lead to various complications. However, new approaches have been introduced over the years, making diagnosis less invasive and more affordable. The albumin-bilirubin (ALBI) score, which was initially developed for hepatocellular carcinoma, has been shown to be correlated with survival, tumor relapse, and post-hepatectomy liver failure. We read with great interest the article by Ewid et al that was recently published in World Journal of Hepatology in which they reported a positive correlation between the ALBI score and inflammatory markers in patients with HCV infection after direct-acting antiviral (DAA) treatment. The ALBI score improved in patients with HCV and was useful for monitoring hepatic function during and after DAA therapy. They reported that the baseline ALBI scores were more favorable in the nonadvanced fibrosis group. Following DAA treatment, the improvement was more evident in the advanced fibrosis group. This score was significantly positively correlated with all noninvasive tests for liver fibrosis before and after DAA therapy. This editorial aimed to critically evaluate the role of the ALBI score as a biomarker in the management of chronic HCV infection, emphasizing its potential value for refining functional assessment, increasing risk stratification, and supporting long-term monitoring in patients treated with DAAs.
Zitieren
APA
Jiménez-Cuevas, E. A., Montoya-López, M., Martínez-Díaz, F. M., Ramírez-Mejía, M. M., & Méndez-Sánchez, N. (2026). Albumin-bilirubin score: Monitoring hepatic function in patients with chronic hepatitis C virus infection. World Journal of Hepatology, 18(7). https://doi.org/10.4254/wjh.114187
Vancouver
Jiménez-Cuevas EA, Montoya-López M, Martínez-Díaz FM, Ramírez-Mejía MM, Méndez-Sánchez N. Albumin-bilirubin score: Monitoring hepatic function in patients with chronic hepatitis C virus infection. World Journal of Hepatology. 2026;18(7). doi:10.4254/wjh.114187
BibTeX
@article{JimnezCuevas2026,
author = {Jiménez-Cuevas, Elsie A and Montoya-López, Mariana and Martínez-Díaz, Fernanda M and Ramírez-Mejía, Mariana M and Méndez-Sánchez, Nahum},
title = {Albumin-bilirubin score: Monitoring hepatic function in patients with chronic hepatitis C virus infection},
journal = {World Journal of Hepatology},
year = {2026},
volume = {18},
number = {7},
doi = {10.4254/wjh.114187}
}
EUVIMED